186 related articles for article (PubMed ID: 11214707)
1. Development of heart failure in bradycardic sick sinus syndrome.
Alboni P; Scarfò S; Fucà G
Ital Heart J; 2001 Jan; 2(1):9-12. PubMed ID: 11214707
[TBL] [Abstract][Full Text] [Related]
2. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction.
Sweeney MO; Hellkamp AS; Ellenbogen KA; Greenspon AJ; Freedman RA; Lee KL; Lamas GA;
Circulation; 2003 Jun; 107(23):2932-7. PubMed ID: 12782566
[TBL] [Abstract][Full Text] [Related]
3. Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure.
Kuch M; Janiszewski M; Mamcarz A; Cudnoch-Jedrzejewska A; Dłuzniewski M
Med Sci Monit; 2009 Jun; 15(6):PH40-8. PubMed ID: 19478711
[TBL] [Abstract][Full Text] [Related]
4. Reduced ejection fraction, sudden cardiac death, and heart failure death in the mode selection trial (MOST): implications for device selection in elderly patients with sinus node disease.
Sweeney MO; Hellkamp AS; Ellenbogen KA; Lamas GA
J Cardiovasc Electrophysiol; 2008 Nov; 19(11):1160-6. PubMed ID: 18554201
[TBL] [Abstract][Full Text] [Related]
5. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
White HD; Aylward PE; Huang Z; Dalby AJ; Weaver WD; Barvik S; Marin-Neto JA; Murin J; Nordlander RO; van Gilst WH; Zannad F; McMurray JJ; Califf RM; Pfeffer MA;
Circulation; 2005 Nov; 112(22):3391-9. PubMed ID: 16301343
[TBL] [Abstract][Full Text] [Related]
6. Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
Freudenberger RS; Hellkamp AS; Halperin JL; Poole J; Anderson J; Johnson G; Mark DB; Lee KL; Bardy GH;
Circulation; 2007 May; 115(20):2637-41. PubMed ID: 17485579
[TBL] [Abstract][Full Text] [Related]
7. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L
Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
[TBL] [Abstract][Full Text] [Related]
8. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
Wilkoff BL;
Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
[TBL] [Abstract][Full Text] [Related]
9. Atrial fibrillation: rate control often better than rhythm control.
Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
[TBL] [Abstract][Full Text] [Related]
10. [Arrhythmic profiles evaluated by Holter's technique in sick sinus syndrome].
Lousada N; Catarino C; Antunes E; Serra J; Patrício L; Valério L; Gracias R; Rato JA
Rev Port Cardiol; 1991 May; 10(5):427-31. PubMed ID: 1910879
[TBL] [Abstract][Full Text] [Related]
11. Management of atrial fibrillation in the elderly.
Aronow WS
Minerva Med; 2009 Feb; 100(1):3-24. PubMed ID: 19182738
[TBL] [Abstract][Full Text] [Related]
12. Beta-blocker underuse in secondary prevention of myocardial infarction.
Everly MJ; Heaton PC; Cluxton RJ
Ann Pharmacother; 2004 Feb; 38(2):286-93. PubMed ID: 14742768
[TBL] [Abstract][Full Text] [Related]
13. [Can reduction in resting heart rate be beneficial for patients?].
Soucek M
Vnitr Lek; 2007 Apr; 53(4):401-3. PubMed ID: 17578174
[TBL] [Abstract][Full Text] [Related]
14. [Heart failure: critical patients].
Fabbri G; Gorini M; Maggioni AP; Oliva F;
G Ital Cardiol (Rome); 2007 Sep; 8(9):568-73. PubMed ID: 17972426
[TBL] [Abstract][Full Text] [Related]
15. Hydralazine in the management of symptomatic sinus bradycardia.
Weiss AT; Rod JL; Gotsman MS; Lewis BS
Eur J Cardiol; 1981; 12(5):261-70. PubMed ID: 7250168
[TBL] [Abstract][Full Text] [Related]
16. High incidence of pacemaker syndrome in patients with sinus node dysfunction treated with ventricular-based pacing in the Mode Selection Trial (MOST).
Link MS; Hellkamp AS; Estes NA; Orav EJ; Ellenbogen KA; Ibrahim B; Greenspon A; Rizo-Patron C; Goldman L; Lee KL; Lamas GA;
J Am Coll Cardiol; 2004 Jun; 43(11):2066-71. PubMed ID: 15172414
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
18. Is sinus bradycardia a factor facilitating overt heart failure?
Alboni P; Brignole M; Menozzi C; Scarfò S
Eur Heart J; 1999 Feb; 20(4):252-5. PubMed ID: 10099918
[No Abstract] [Full Text] [Related]
19. Heart failure and diabetes: left ventricular systolic function.
Palmiero P; Macello M; De Pascalis S
Minerva Cardioangiol; 2006 Apr; 54(2):241-8. PubMed ID: 16778755
[TBL] [Abstract][Full Text] [Related]
20. Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial.
Am Heart J; 2002 Oct; 144(4):597-607. PubMed ID: 12360154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
